Human cytomegalovirus: challenges, opportunities and new drug development (Q28376935)

Antiviral Chemistry & Chemotherapy

Europe PubMed Central

title

Human cytomegalovirus: challenges, opportunities and new drug development (English)

0 references

0 references

A K Field

1

0 references

language of work or name

English

0 references

publication date

September 1999

0 references

published in

0 references

volume

10

0 references

issue

5

0 references

page(s)

219-32

0 references

cites work

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Summary of the II International Symposium on Cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Therapeutic options for resistant cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

An in vivo model of human cytomegalovirus retinal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Reproduction of antiviral effect in an in vivo model of human cytomegalovirus retinal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Generation of a nude mouse tumor model for in vivo replication of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Quanolirones I and II, two new human cytomegalovirus protease inhibitors produced by Streptomyces sp. WC76535.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Human cytomegalovirus cell tropism and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

How to overcome resistance of influenza A viruses against adamantane derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501

PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000501